Mattia Zaffaroni

ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial

Giulia Marvaso, Giulia Corrao, Mattia Zaffaroni et al. · The Lancet Oncology · 2025 · 77 citations

Medicine, Oncology, Urology +11

Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology

Giulia Marvaso, Barbara Alicja Jereczek‐Fossa, Mattia Zaffaroni et al. · The Lancet Oncology · 2024 · 34 citations

Medicine, Oncology, Urology +14

More than Five Decades of Proton Therapy: A Bibliometric Overview of the Scientific Literature

Maria Giulia Vincini, Mattia Zaffaroni, Marco Schwarz et al. · Cancers · 2023 · 23 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?

Giulia Marvaso, Giulia Corrao, Olga Oneta et al. · Clinical & Translational Oncology · 2021 · 21 citations

Medicine, Oncology, Radiation Oncology +14

The role of radiomics in tongue cancer: A new tool for prognosis prediction

Chiara Mossinelli, Marta Tagliabue, Francesca Ruju et al. · Head & Neck · 2023 · 20 citations · Full text

Medicine, Oncology, Radiology +16